Clinical Trial Update: Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

View source ↗

Summary

This clinical trial update outlines a study to determine how common MASLD is and what risk factors are associated with metabolic-associated hepatic steatosis in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Latent Autoimmune Diabetes in Adults
• Liver Fibrosis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes, Liver Steatoses | Status: NOT_YET_RECRUITING